These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9121598)

  • 1. Risk factors for HCV infection in two haemodialysis units in The Netherlands.
    Keur I; Schneeberger PM; van der Graaf Y; Vos J; van Dijk WC; van Doorn LJ
    Neth J Med; 1997 Mar; 50(3):97-101. PubMed ID: 9121598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and risk factors of hepatitis C virus infection in a haemodialysis unit.
    Forns X; Fernández-Llama P; Pons M; Costa J; Ampurdanés S; López-Labrador FX; Olmedo E; López-Pedret J; Darnell A; Revert L; Sánchez-Tapias JM; Rodés J
    Nephrol Dial Transplant; 1997 Apr; 12(4):736-40. PubMed ID: 9141004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C infection in dialysis patients in Israel.
    Weinstein T; Tur-Kaspa R; Chagnac A; Korzets A; Ori Y; Zevin D; Herman M; Gafter U
    Isr Med Assoc J; 2001 Mar; 3(3):174-7. PubMed ID: 11303373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased prevalence and incidence of HCV markers in haemodialysis units: a multicentric French survey.
    Sauné K; Kamar N; Miédougé M; Weclawiak H; Dubois M; Izopet J; Rostaing L
    Nephrol Dial Transplant; 2011 Jul; 26(7):2309-16. PubMed ID: 21097646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and risk factors of hepatitis C and B virus infections in hemodialysis patients and their spouses: a multicenter study in Beijing, China.
    Su Y; Yan R; Duan Z; Norris JL; Wang L; Jiang Y; Xing W; Chen Y; Xiao Y; Li L; Tao J; Wang N
    J Med Virol; 2013 Mar; 85(3):425-32. PubMed ID: 23341370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus infections in dialysis centers in The Netherlands: a national survey by serological and molecular methods.
    Schneeberger PM; Keur I; van der Vliet W; van Hoek K; Boswijk H; van Loon AM; van Dijk WC; Kauffmann RH; Quint W; van Doorn LJ
    J Clin Microbiol; 1998 Jun; 36(6):1711-5. PubMed ID: 9620405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of hepatitis C virus genotypes among hemodialysis patients in Tehran--a multicenter study.
    Hosseini-Moghaddam SM; Keyvani H; Kasiri H; Kazemeyni SM; Basiri A; Aghel N; Alavian SM
    J Med Virol; 2006 May; 78(5):569-73. PubMed ID: 16555284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of association between hepatitis C virus genotype 2b and nosocomial transmissions in hemodialysis centers from southern Brazil.
    da Silva NM; Germano FN; Mendoza-Sassi RA; Seuánez HN; Soares MA; de Martinez AM
    Virol J; 2013 May; 10():167. PubMed ID: 23714239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low prevalence of hepatitis C virus infection in hemodialysis units: effect of isolation?
    Harmankaya O; Cetin B; Obek A; Seber E
    Ren Fail; 2002 Sep; 24(5):639-44. PubMed ID: 12380910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of hepatitis C virus in patients with terminal renal disease undergoing dialysis in southern Brazil: prevalence, risk factors, genotypes, and viral load dynamics in hemodialysis patients.
    Vidales-Braz BM; da Silva NM; Lobato R; Germano FN; da Mota LD; Barros EJ; de Martinez AM
    Virol J; 2015 Feb; 12():8. PubMed ID: 25644891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B and C virus infection among hemodialysis patients in Yogyakarta, Indonesia: Prevalence and molecular evidence for nosocomial transmission.
    Rinonce HT; Yano Y; Utsumi T; Heriyanto DS; Anggorowati N; Widasari DI; Lusida MI; Soetjipto ; Prasanto H; Hotta H; Hayashi Y
    J Med Virol; 2013 Aug; 85(8):1348-61. PubMed ID: 23919229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatitis C virus infection among long-term hemodialysis patients].
    Lu A; Wang A; Sheng R
    Zhonghua Nei Ke Za Zhi; 1997 Jun; 36(6):402-5. PubMed ID: 10374301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of hepatitis C virus seroconversion resulting from nosocomial transmission on a haemodialysis unit: implications for infection control and laboratory screening.
    Irish DN; Blake C; Christophers J; Craske JE; Burnapp L; Abbs IC; MacMahon EM; Muir P; Banatvala JE; Simmonds P
    J Med Virol; 1999 Oct; 59(2):135-40. PubMed ID: 10459146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, genotypes and risk factors associated with hepatitis C virus infection in hemodialysis patients in Campo Grande, MS, Brazil.
    Freitas SZ; da Cunha RV; Martins RM; Teles SA; Ibanhes ML; Motta-Castro AR
    Mem Inst Oswaldo Cruz; 2008 Jun; 103(4):405-8. PubMed ID: 18660998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus infection among dialysis patients in Tunisia: incidence and molecular evidence for nosocomial transmission.
    Hmaied F; Ben Mamou M; Saune-Sandres K; Rostaing L; Slim A; Arrouji Z; Ben Redjeb S; Izopet J
    J Med Virol; 2006 Feb; 78(2):185-91. PubMed ID: 16372289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus infection in four haemodialysis units of southern Italy: epidemiological report.
    Scotto G; Avcella F; Panunzio M; Savastano AM; Ktena M; Forcella M; Fazio V; Calzone G; Passione A; Procaccini D; Demin A; Stallone C
    Eur J Epidemiol; 1999 Mar; 15(3):217-23. PubMed ID: 10395050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus in chronic dialysis patients.
    Natov SN; Pereira BJ
    Minerva Urol Nefrol; 2005 Sep; 57(3):175-97. PubMed ID: 15986016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of antibodies to hepatitis C in dialysis patients and transplant recipients with possible routes of transmission.
    Conway M; Catterall AP; Brown EA; Tibbs C; Gower PE; Curtis JR; Coleman JC; Murray-Lyon IM
    Nephrol Dial Transplant; 1992; 7(12):1226-9. PubMed ID: 1283447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of antibodies to hepatitis C virus in three haemodialysis centres in south-western Poland.
    Hruby Z; Sliwiński J; Molin I; Zalewska M; Knysz B; Czyz W; Steciwko A; Bogucki J; Gładysz A
    Nephrol Dial Transplant; 1993; 8(8):740-3. PubMed ID: 7692355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occasional infection of hepatitis C virus occurring in haemodialysis units identified by serial monitoring of the virus infection.
    Iwasaki Y; Esumi M; Hosokawa N; Yanai M; Kawano K
    J Hosp Infect; 2000 May; 45(1):54-61. PubMed ID: 10833344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.